跳至主要内容
临床试验/NCT02603315
NCT02603315已完成不适用

To Assess the Correlation Between the Predictive Factor of Vascularity (CD74) in Malignant Pleural Mesothelioma and Treatment Results (Response Rate, and Overall Survival )

Ain Shams University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
to correlate the results of the vascularity marker of pleural mesothelioma CD74 of patients attended to Ain Shams University hospitals with the result response of treatment by chemotherapy ,overall survival and progreeion free survival

研究概览

简要总结

The purpose of this study is to To assess the correlation between the predictive factor of vascularity (CD74) in malignant pleural mesothelioma and treatment results (response rate, and overall survival) .

详细描述

This is a randomized controlled retrospective study through Examination of paraffin blocks of the patient selected to be included in the study for assessment of the selected vascularity marker of malignant pleural mesothelioma of both types . The CD74 (LN2) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed paraffin-embedded tissue sections using Immunohistochemistry test methods.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
39 Years 至 84 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histopathological confirmation of malignant pleural mesothelioma .
  • Full clinical data.
  • Availability for follow up: Personal communication will be attempted in order to collect missing information.
  • 3-The files of all patients will be reviewed to analyze the following :
  • Operative data if done .
  • Pathological review and immunohistochemistry.
  • Laboratory investigations: (routine investigations: complete blood picture,liver and renal function test)
  • Radiological investigations:( CXR and CT-chest, Abdominal and pelvic U\S and MRI ).
  • Treatment protocols applied: Radiotherapy and Chemotherapy.
  • Response and survival after treatment .

排除标准

  • cases not receive chemotherapy ,on available of evaluation after treatment

结局指标

主要结局

to correlate the results of the vascularity marker of pleural mesothelioma CD74 of patients attended to Ain Shams University hospitals with the result response of treatment by chemotherapy ,overall survival and progreeion free survival

时间窗: 3-4 months

The cases diagnosed and receive at the least 2-3 cycles of chemotherapy and evaluated after treatment

次要结局

  • assessment of vascular enothelial growth factor (VEGF) in patient with malignant pleural mesothelioma who attended to Ain Shams University and made comparison with the result of CD 74(3-4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Muna Sami Jassim

Doctor in clinical oncology and nuclear medicine department

Ain Shams University

研究点 (1)

Loading locations...

相似试验